Held April 6-9 in Nashville, the event equips clinicians, policymakers, and public safety leaders with strategies to address nitazenes, trafficking, and pain management.
Held April 6-9 in Nashville, the event equips clinicians, policymakers, and public safety leaders with strategies to address nitazenes, trafficking, and pain management.
CNN’s Chief Medical Correspondent joins Dr. Eric Garland, Dan Kruger to discuss redefining pain management and recovery at April 6-9 event in Nashville.
CNN’s Chief Medical Correspondent joins Dr. Eric Garland, Dan Kruger to discuss redefining pain management and recovery at April 6-9 event in Nashville.
More than 800 participants joined the 2025 virtual program; the December 4-6, 2026 event will deepen engagement through richer education and collaborative learning.
More than 800 participants joined the 2025 virtual program; the December 4-6, 2026 event will deepen engagement through richer education and collaborative learning.
The combination of olanzapine and samidorphan (OLZ/SAM) may have a significant long-term treatment benefit on the negative symptoms of schizophrenia, according to research presented at the 2025 NEI Spring Congress.
The combination of olanzapine and samidorphan (OLZ/SAM) may have a significant long-term treatment benefit on the negative symptoms of schizophrenia, according to research presented at the 2025 NEI Spring Congress.
According to a recent literature review, L-methylfolate (LMF) is an effective adjunct treatment in selective serotonin reuptake inhibitor (SSRI)-resistant depression, particularly at 15 mg/day.
According to a recent literature review, L-methylfolate (LMF) is an effective adjunct treatment in selective serotonin reuptake inhibitor (SSRI)-resistant depression, particularly at 15 mg/day.
Deutetrabenazine showed significant efficacy and high specificity in inhibiting its primary target, VMAT2,, in functional assessments of the drug’s deuterated metabolites. Findings were reported at the inaugural poster session at the NEI...
Deutetrabenazine showed significant efficacy and high specificity in inhibiting its primary target, VMAT2,, in functional assessments of the drug’s deuterated metabolites. Findings were reported at the inaugural poster session at the NEI...
A systematic review presented at the 2025 NEI Spring Congress found that effective pharmacologic interventions for pathological gambling (PG) remain limited.
A systematic review presented at the 2025 NEI Spring Congress found that effective pharmacologic interventions for pathological gambling (PG) remain limited.
A recent quality improvement project presented in a poster at the 2025 NEI Spring Congress explored ways to improve nutritional screening and education in outpatient mental health settings.
A recent quality improvement project presented in a poster at the 2025 NEI Spring Congress explored ways to improve nutritional screening and education in outpatient mental health settings.
Join Dr Craig Chepke and D. Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and D. Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
The FDA has approved a supplemental biologics license application for lecanemab-irmb (Leqembi, Eisai Co., Ltd.; Biogen Inc.), an intravenous treatment (IV) for early Alzheimer disease (AD).
The FDA has approved a supplemental biologics license application for lecanemab-irmb (Leqembi, Eisai Co., Ltd.; Biogen Inc.), an intravenous treatment (IV) for early Alzheimer disease (AD).
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
The AbbVie Medical Affairs Partner Spotlight features peer-informed content developed to help support your clinical decision-making in mental health. Browse resources now!
ABBV-US-02301-MC, V1.0 | Approved 01/2026 | AbbVie Medical Affairs
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
n this video, Tardive Dyskinesia Section Editor Amber Hoberg, MSN, APRN, PMHNP-BC, of Med Management Associates, offers clinical pearls that clinicians can implement to optimize their tardive dyskinesia care.
n this video, Tardive Dyskinesia Section Editor Amber Hoberg, MSN, APRN, PMHNP-BC, of Med Management Associates, offers clinical pearls that clinicians can implement to optimize their tardive dyskinesia care.
Greg Mattingly, MD, gives exclusive updates from day 2 of the National Academy of Sciences Adult Attention-Deficit/Hyperactivity Disorder: Diagnosis, Treatment, and Implications for Drug Development Workshop.
Greg Mattingly, MD, gives exclusive updates from day 2 of the National Academy of Sciences Adult Attention-Deficit/Hyperactivity Disorder: Diagnosis, Treatment, and Implications for Drug Development Workshop.
Dr Maletic discusses how new research shows promise for advancing our comprehension of brain networks, circuits, and neurotransmitters to benefit those with neurological and psychiatric disorders
Dr Maletic discusses how new research shows promise for advancing our comprehension of brain networks, circuits, and neurotransmitters to benefit those with neurological and psychiatric disorders
In his recent NEI Congress session, Vladimir Maletic, MD, MS, University of South Carolina, Greenville, examined the neurobiologic underpinning of major psychiatric conditions such as major depressive disorder, bipolar disorder, and anxiety....
In his recent NEI Congress session, Vladimir Maletic, MD, MS, University of South Carolina, Greenville, examined the neurobiologic underpinning of major psychiatric conditions such as major depressive disorder, bipolar disorder, and anxiety....
President-Elect of the APA, Ramaswamy Viswanathan, MD, DrMedSc shares what clinicians need to know about Seasonal Affective Disorder (SAD), and how to better support patients experiencing symptoms.
President-Elect of the APA, Ramaswamy Viswanathan, MD, DrMedSc shares what clinicians need to know about Seasonal Affective Disorder (SAD), and how to better support patients experiencing symptoms.
Dr Jonathan Meyer discusses his NEI 2023 session "Level Up: Using Plasma Levels, Pharmacokinetics and Pharmacodynamics to Guide Antipsychotic Prescribing," the importance of understanding the kinetics of long-acting injectables, and more.
Dr Jonathan Meyer discusses his NEI 2023 session "Level Up: Using Plasma Levels, Pharmacokinetics and Pharmacodynamics to Guide Antipsychotic Prescribing," the importance of understanding the kinetics of long-acting injectables, and more.
In this Q&A, Brooke Kempf, PMHNP-BC, Steering Committee, Psych Congress, and Jonathan Meyer, MD, Consultant, Psych Congress, outline the hallmark characteristics of DIP and TD.
In this Q&A, Brooke Kempf, PMHNP-BC, Steering Committee, Psych Congress, and Jonathan Meyer, MD, Consultant, Psych Congress, outline the hallmark characteristics of DIP and TD.
Held April 6-9 in Nashville, the event equips clinicians, policymakers, and public safety leaders with strategies to address nitazenes, trafficking, and pain management.
Held April 6-9 in Nashville, the event equips clinicians, policymakers, and public safety leaders with strategies to address nitazenes, trafficking, and pain management.
Edward Kaftarian, MD, Steering Committee, Psych Congress, provides an update on the current state of HIPAA requirements for clinicians practicing via telehealth.
Edward Kaftarian, MD, Steering Committee, Psych Congress, provides an update on the current state of HIPAA requirements for clinicians practicing via telehealth.
In this discussion, Brooke Kempf, PMHNP-BC, and Jonathan Meyer, MD, unpack why anticholinergics are ineffective—and potentially harmful—in patients with tardive dyskinesia (TD).
In this discussion, Brooke Kempf, PMHNP-BC, and Jonathan Meyer, MD, unpack why anticholinergics are ineffective—and potentially harmful—in patients with tardive dyskinesia (TD).
CNN’s Chief Medical Correspondent joins Dr. Eric Garland, Dan Kruger to discuss redefining pain management and recovery at April 6-9 event in Nashville.
CNN’s Chief Medical Correspondent joins Dr. Eric Garland, Dan Kruger to discuss redefining pain management and recovery at April 6-9 event in Nashville.
In this video, Psych Congress Steering Committee Member Edward Kaftarian, MD, dives into potential legal gray areas that clinicians may encounter when engaging in cross-state telepsychiatry.
In this video, Psych Congress Steering Committee Member Edward Kaftarian, MD, dives into potential legal gray areas that clinicians may encounter when engaging in cross-state telepsychiatry.
In this video, filmed at Psych Congress Elevate 2025, Steering Committee Member Edward Kaftarian, MD, walks clinicians through current and forthcoming regulations regarding the prescription of controlled substances via telehealth.
In this video, filmed at Psych Congress Elevate 2025, Steering Committee Member Edward Kaftarian, MD, walks clinicians through current and forthcoming regulations regarding the prescription of controlled substances via telehealth.
In this video filmed at Psych Congress Elevate 2023, Steering Committee Member Edward Kaftarian, MD, breaks down the definitions of telehealth and telemedicine.
In this video filmed at Psych Congress Elevate 2023, Steering Committee Member Edward Kaftarian, MD, breaks down the definitions of telehealth and telemedicine.
In this video, Steven Krozer, PMHNP-BC, MSN, BSN, APRN, discusses how clinicians can effectively establish strong therapeutic relationships and offer patients the highest quality of care when using hybrid models of treatment.
In this video, Steven Krozer, PMHNP-BC, MSN, BSN, APRN, discusses how clinicians can effectively establish strong therapeutic relationships and offer patients the highest quality of care when using hybrid models of treatment.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Lydia Tschoe, MHA, and Karen Scott, MD, address the concern that pregnancy-associated deaths involving opioids have more than doubled between 2007 and 2016.
Lydia Tschoe, MHA, and Karen Scott, MD, address the concern that pregnancy-associated deaths involving opioids have more than doubled between 2007 and 2016.
Craig Chepke, M.D., FAPA: From telepsychiatry to drive-up injection sites, new, inventive strategies for patient-centered care spurred by COVID-19 pandemic could drive lasting change.
Craig Chepke, M.D., FAPA: From telepsychiatry to drive-up injection sites, new, inventive strategies for patient-centered care spurred by COVID-19 pandemic could drive lasting change.
BLOG: How much energy will it take to overcome the inertia that has befallen our daily lives? Will we reenact a simulacrum of how things were before, or will we find, deep within ourselves, the capacity for reimagination of what could be?
BLOG: How much energy will it take to overcome the inertia that has befallen our daily lives? Will we reenact a simulacrum of how things were before, or will we find, deep within ourselves, the capacity for reimagination of what could be?
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Dr Garofoli discusses the key changes in the CDC's 2022 Opioid Guideline Update and their impact on clinical practice, highlights the expanded scope of the guidelines to all outpatient settings, the nuanced approach to pain management, and...
Dr Garofoli discusses the key changes in the CDC's 2022 Opioid Guideline Update and their impact on clinical practice, highlights the expanded scope of the guidelines to all outpatient settings, the nuanced approach to pain management, and...
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.